Unveiling COVID-19-associated organ-specific cell types and cell-specific pathway cascade

Area of Science:

• Virology
• Genomics
• Biochemistry

Background:

• COVID-19, caused by SARS-CoV-2, utilizes Angiotensin-converting enzyme 2 (ACE2) as a primary host cell receptor.
• ACE2 expression is notably high in organs beyond the lungs, including the bladder, ileum, kidney, and liver.

Purpose of the Study:

• To identify cell types with high ACE2 expression across multiple human tissues.
• To explore protein-protein interaction networks and identify potential biomarkers for COVID-19 infection.
• To investigate the role of identified pathways and biomarkers in disease pathogenesis and vulnerability.

Main Methods:

• Single-cell RNA sequencing data analysis from five human tissues.
• Construction and analysis of protein-protein interaction networks.
• K-means clustering for biomarker identification and PageRank algorithm for pathway analysis.

Main Results:

• Identified cell types with high ACE2 expression and established protein-protein interaction networks.
• Discovered angiotensin and PPAR family proteins as crucial functional hubs and potential biomarkers.
• Revealed the renin-angiotensin system and PPAR signaling pathway's role in enhancing COVID-19 infection, including links to insulin resistance and diabetic patient vulnerability.

Conclusions:

• Angiotensin and PPAR family proteins are key regulators in COVID-19 infection pathways.
• The renin-angiotensin system and PPAR signaling pathway are critical for infection progression.
• These proteins represent promising therapeutic targets for COVID-19 treatment, particularly for vulnerable populations like diabetic patients.